NCT02461797View on ClinicalTrials.gov

Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Allergic Rhinitis
Interventions
OTHER

healthy controls

biopsy of nasal mucosa for healthy controls

OTHER

AR patients without medication

biopsy of nasal mucosa for allergic rhinitis patients without allergy medication

OTHER

AR patients with use of nasal corticoid spray

biopsy of nasal mucosa for allergic rhinitis patients with use of nasal corticoid spray

Trial Locations (1)

3000

ORL, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02461797 - Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients | Biotech Hunter | Biotech Hunter